Remove 2020 Remove Individual Remove Provider Remove Screening
article thumbnail

Is there enough time for prevention in primary care?

Common Sense Family Doctor

Meanwhile, the estimated time needed to provide guideline-recommended preventive care, chronic disease care, and acute care to a nationally representative panel of 2,500 adult patients is an impossible 26.7 Since 2020, the starting ages for breast, lung, and colorectal cancer screening were lowered to 40, 50, and 45 years, respectively.

article thumbnail

"Survival Mode": Experiences of moral distress in Canadian primary care professionals during and after the COVID-19 pandemic [COVID-19]

Annals of Family Medicine

Objective: This project explored the presence, nature, and effects of moral distress in Canadian primary healthcare professionals from two provinces during (March 2020-May 2023) and after the COVID-19 pandemic. Intervention/Instrument: Individual semi-structured interviews and review of pertinent case-relevant documents.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

COVID At-Home Antigen Tests: If at First You Don’t Succeed Try, Try and Try Again

FDA Law Blog

After two negative tests, you should consider a molecular test, or call your healthcare provider. If the third test is negative, you should test again with an antigen test, or get a laboratory molecular-based test, or call your healthcare provider. If the second test is negative, you should test again 48 hours after the second test.

article thumbnail

Mastering Responses to FDA 510(k) AI Letters: A Strategic Approach

FDA Law Blog

By Day 100 If MDUFA Decision is not reached by Day 100, FDA provides Missed MDUFA Decision Communication that identifies outstanding review issues. Performance Metric FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 Average Number of FDA Days to MDUFA IV Decision 72.62 By Day 90 FDA sends final MDUFA Decision on 510(k).

article thumbnail

Episode 275: Anti-Racism in Medicine Series – Episode 19 – Reframing the Opioid Epidemic: Anti-Racist Praxis, Racial Health Inequities, and Harm Reduction

The Clinical Problem Solvers

Screening for substance use and offering connections to treatment and community-based services are important strategies that clinicians can implement in their own practice today. Between 2007 – 2019, Black individuals experienced a higher death rate for opioid overdose deaths than any other racial or ethnic group.

article thumbnail

Episode 322: Antiracism in Medicine – Episode 24 – Leveraging Narrative Medicine to Cultivate Antiracist Praxis

The Clinical Problem Solvers

She discovered narrative medicine, and to her, it was about finding and retelling individual and structural stories in antiracist ways. Listening to individual stories within the context of their structural stories is important. Listening to individual stories within the context of their structural stories is important.

article thumbnail

Texas invests $50M in psychedelic drug research to treat addiction

Medical Xpress

But experts say the risks can be lowered through heart screenings, close monitoring and giving magnesium before and during treatment, The Times added in its report. The content is provided for information purposes only. However, we do not guarantee individual replies due to the high volume of messages.